Role of the immune system in cardiac tissue damage and repair following myocardial infarction. 2017

Arman Saparov, and Vyacheslav Ogay, and Talgat Nurgozhin, and William C W Chen, and Nurlan Mansurov, and Assel Issabekova, and Jamilya Zhakupova
Department of Biomedical Sciences, Nazarbayev University School of Medicine, Nazarbayev University, Astana, 010000, Kazakhstan. asaparov@nu.edu.kz.

BACKGROUND The immune system plays a crucial role in the initiation, development, and resolution of inflammation following myocardial infarction (MI). The lack of oxygen and nutrients causes the death of cardiomyocytes and leads to the exposure of danger-associated molecular patterns that are recognized by the immune system to initiate inflammation. RESULTS At the initial stage of post-MI inflammation, the immune system further damages cardiac tissue to clear cell debris. The excessive production of reactive oxygen species (ROS) by immune cells and the inability of the anti-oxidant system to neutralize ROS cause oxidative stress that further aggravates inflammation. On the other hand, the cells of both innate and adaptive immune system and their secreted factors are critically instrumental in the very dynamic and complex processes of regulating inflammation and mediating cardiac repair. CONCLUSIONS It is important to decipher the balance between detrimental and beneficial effects of the immune system in MI. This enables us to identify better therapeutic targets for reducing the infarct size, sustaining the cardiac function, and minimizing the likelihood of heart failure. This review discusses the role of both innate and adaptive immune systems in cardiac tissue damage and repair in experimental models of MI.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D056704 Adaptive Immunity Protection from an infectious disease agent that is mediated by B- and T- LYMPHOCYTES following exposure to specific antigen, and characterized by IMMUNOLOGIC MEMORY. It can result from either previous infection with that agent or vaccination (IMMUNITY, ACTIVE), or transfer of antibody or lymphocytes from an immune donor (IMMUNIZATION, PASSIVE). Acquired Immunity,Hybrid Immunity,Adaptive Immune Response,Adoptive Immunity,Immunity, Adaptive,Hybrid Immunities,Immune Response, Adaptive,Immunity, Acquired,Immunity, Adoptive,Immunity, Hybrid,Response, Adaptive Immune

Related Publications

Arman Saparov, and Vyacheslav Ogay, and Talgat Nurgozhin, and William C W Chen, and Nurlan Mansurov, and Assel Issabekova, and Jamilya Zhakupova
March 2021, International journal of molecular sciences,
Arman Saparov, and Vyacheslav Ogay, and Talgat Nurgozhin, and William C W Chen, and Nurlan Mansurov, and Assel Issabekova, and Jamilya Zhakupova
July 2021, Cells,
Arman Saparov, and Vyacheslav Ogay, and Talgat Nurgozhin, and William C W Chen, and Nurlan Mansurov, and Assel Issabekova, and Jamilya Zhakupova
April 2016, International journal of cardiology,
Arman Saparov, and Vyacheslav Ogay, and Talgat Nurgozhin, and William C W Chen, and Nurlan Mansurov, and Assel Issabekova, and Jamilya Zhakupova
April 2013, Current vascular pharmacology,
Arman Saparov, and Vyacheslav Ogay, and Talgat Nurgozhin, and William C W Chen, and Nurlan Mansurov, and Assel Issabekova, and Jamilya Zhakupova
December 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Arman Saparov, and Vyacheslav Ogay, and Talgat Nurgozhin, and William C W Chen, and Nurlan Mansurov, and Assel Issabekova, and Jamilya Zhakupova
August 2015, Circulation research,
Arman Saparov, and Vyacheslav Ogay, and Talgat Nurgozhin, and William C W Chen, and Nurlan Mansurov, and Assel Issabekova, and Jamilya Zhakupova
October 2011, Journal of cardiovascular translational research,
Arman Saparov, and Vyacheslav Ogay, and Talgat Nurgozhin, and William C W Chen, and Nurlan Mansurov, and Assel Issabekova, and Jamilya Zhakupova
June 1997, Panminerva medica,
Arman Saparov, and Vyacheslav Ogay, and Talgat Nurgozhin, and William C W Chen, and Nurlan Mansurov, and Assel Issabekova, and Jamilya Zhakupova
December 2000, Journal of molecular and cellular cardiology,
Arman Saparov, and Vyacheslav Ogay, and Talgat Nurgozhin, and William C W Chen, and Nurlan Mansurov, and Assel Issabekova, and Jamilya Zhakupova
December 2012, British journal of pharmacology,
Copied contents to your clipboard!